A Translational Approach to Addressing COVID-19
From the Director
Read Director’s Messages from Christopher P. Austin, M.D., about NCATS’ response to COVID-19.
Video Spotlight
Watch this video for a behind the scenes look at how a collaborative NIH study to measure undetected coronavirus cases came together or read more about the study.
The process of developing new therapies and getting them to patients is long and difficult. During public health emergencies, science — and the process of turning observations into new therapies — must move faster than ever. That is where translational science comes in.
Translational science is focused on streamlining the process of moving (“translating”) lab findings into medical practice and treatments to improve health and well-being. NCATS is focused on advancing the science of translation.
NCATS is supporting research activities spanning the translational science spectrum to address the novel coronavirus 2019 (SARS-CoV-2) and the disease it causes (COVID-19). With the aim of accelerating translational research across all diseases, NCATS has developed research tools, technologies, expertise and collaborative networks that can quickly pivot to address urgent public health issues.
In addition, by using its networks to draw together experts with necessary and complementary skills, knowledge and experience, NCATS is enabling projects to cut through operational roadblocks.
Video Spotlight
Watch this video for a behind the scenes look at how a collaborative NIH study to measure undetected coronavirus cases came together or read more about the study.
Research Activities
- Learn about NCATS projects that are leveraging existing platform approaches to help detect coronavirus cases and find ways to the treat infection.
- Learn about collaborations that are speeding research related to COVID-19.
Additional Resources
Find a Clinical Trial
Visit the U.S. Department of Health and Human Services Combat COVID web portal to find information about participating in clinical trials — including trials coordinated by NCATS — as well as donating blood and plasma.
Funding
Open NCATS opportunities: NCATS has issued several notices of special interest that highlight the urgent need for research on SARS-CoV-2 and COVID-19. See all open NCATS funding opportunities.
Resources from the NIH Office of Extramural Research:
- COVID-19 information for NIH applicants and recipients of NIH funding
- FAQs for researchers looking for COVID funding
Updates from Grantees and Partners
NCATS-supported researchers are actively working on a variety of efforts to address the pandemic. See all grantee and partner updates.
NIH and CDC COVID-19 Resources
- Stay on top of the latest announcements and research information from NIH.
- Get public health updates and resources from the Centers for Disease Control and Prevention, including data and forecasts, information about symptoms and testing, and resources for stress and coping.
- Learn about the federal government response to COVID-19.
Image Caption: This scanning electron microscope image shows SARS-CoV-2 (round magenta objects) emerging from the surface of cells cultured in the lab. SARS-CoV-2, also known as 2019-nCoV, is the virus that causes COVID-19. The virus shown was isolated from a patient in the United States. (National Institute of Allergy and Infectious Diseases, Rocky Mountain Laboratories)